Navigation Links
MaxCyte Debuts the STX Scalable Transfection System at the A/C/T Assays & Cellular Targets Meeting
Date:9/23/2008

GAITHERSBURG, Md., Sept. 23 /PRNewswire/ -- MaxCyte, Inc., the pioneer in scalable, high performance cell loading systems, announces that they will be conducting a Product Demonstration of the MaxCyte STX Scalable Transfection System on Thursday, September 25, 2008, at 10:00AM PDT, at the A/C/T Assays & Cellular Targets Conference in San Diego, California.

According to Dr. Madhusudan Peshwa, Vice President of Research and Development at MaxCyte, "The MaxCyte STX Scalable Transfection System can be used to transfect primary cells, cell lines, and stem cells with a range of molecules, including DNA plasmids, different types of RNA, proteins, etc., with very high efficiency. Over ten billion cells can be transfected in 30 minutes. This scale and capability can greatly improve the productivity of drug discovery laboratories. We are pleased to have the opportunity to demonstrate this technology at the A/C/T Meeting."

"We are very excited that the pharmaceutical industry views the MaxCyte STX technology as key to reducing drug discovery bottlenecks," says MaxCyte President and CEO, Doug Doerfler. "The MaxCyte STX can produce a large number of transfected cells in minutes compared to current time-consuming and inconsistent methods. Cells modified using the MaxCyte STX can be used on the research scale and in high-throughput screening assays. The faster you can get to the assay, the more compounds you can screen for biological activity, and the greater your likelihood of finding a successful drug candidate."

After the Product Demonstration, MaxCyte scientists will be available at the A/C/T Meeting to answer any technical questions relative to the performance and operation of the MaxCyte STX Scalable Transfection System.

About MaxCyte

MaxCyte specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of innovative therapeutic products. Drawing on its cell therapy expertise, MaxCyte
'/>"/>

SOURCE MaxCyte, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. MaxCyte to Present at BIO-Europe Spring 2008 Conference
2. Binex and MaxCyte Collaborate on Cancer Immunotherapy Research
3. Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan
4. 2008 National Ergonomics Conference Schedule Announced, Features Four New Tracks of Programming and Focus on Corporate Sustainability and Productivity; Most Product Debuts in Expos 14-Year History
5. National Stem Cell Holding, Inc. (Ticker NHGI) Subsidiary Proteoderm, Inc. Debuts Cosmoceutical Line at the 2008 World Congress on Anti-Aging Medicine
6. Polymathic Analytical Labs Debuts at World's Largest Medical Design & Manufacturing Exhibition
7. PAL Health Technologies Debuts Xtremityscan System at Western Podiatric Medical Congress
8. Bluestar Silicones Debuts New Soft Elastomers at Medical Device & Manufacturing East Expo
9. International Center for Adult Stem Cell Education Debuts at Spinal Cord Injury Symposium in Greece
10. First-Ever Cancer and Careers Seminar Debuts in Orange County
11. Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...November24/PRNewswire-FirstCall/--deCODE,genetics,...fits,"firstday"motionsbytheU.S.BankruptcyCourtfort...lastweekfiledavoluntarypetitionfor,reliefunderChap...ptcyCourt. , TheordersissuedbytheBankruptcyCo...uringtheChapter11proceedings.Inparticular,the,comp...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--NeurogesX,Inc.(Nasdaq:...ngandcommercializingnovelpainmanagementtherapies,a...xecutiveOfficer,isscheduledtopresentatthe21stAnnua...1-2,2009atTheNewYorkPalaceHotelinNewYork,NewYork. ...Officer,willbeavailabletorespondtoquestionsduringt...
(Date:11/24/2009)...ewswire/--BlueMarbleEnergyCorp.announcedtodaythatt...DA)wererecentlyawarded$2millionbyWashingtonState,s...te/publicpartnershiptoconstructthestate,sfirstspec..., "Thisinvestmentwillsignificantlyspeedthedevelop...lnCounty,"saidBlueMarbleEnergyCEOKellyOgilvie."Wea...
(Date:11/24/2009)...pointhasbeenmetforpatientswithadvanced-stage,orrec...PRNewswire-FirstCall/-AEternaZentarisInc.(NASDAQ: ...calcompanyfocusedonendocrinetherapyandoncology,tod...hitstargetedcytotoxicpeptideconjugate,AEZS-108(for...metrialcancer.Inapersonalizedhealthcareapproach,th...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...ts Results for the First Three Months of 2008., C... today results for the three month period ended Ma...the following results:, Genmab,s revenues were DK...st quarter of 2008. In the same period of 2007, Ge.... USD 17 million)., An operating loss of DKK 197 ...
... The automation of,transaction-based processing is...n the United States. Foresight Corporation of Dubl...le of installations of Transaction,Insight(R) - th...., Transaction automation techniques enable healt...ficantly by integrating validation, error,reportin...
... DIEGO, May 28 Boston,Scientific Corporation (NYS...,announced that Boston Scientific has completed it...the definitive agreement announced on April 16.,Un...tstanding CryoCor,shares are entitled to receive $...ly $17.6 million. CryoCor is now an indirect, whol...
Other Biology Technology:Genmab Announces 2008 First Quarter Results 2Genmab Announces 2008 First Quarter Results 3Genmab Announces 2008 First Quarter Results 4New Trend Sweeping Nation's Health Plans: Transaction Automation 2Boston Scientific Completes Acquisition of CryoCor 2Boston Scientific Completes Acquisition of CryoCor 3
(Date:11/24/2009)...ed a protein that may help gut bacteria bind to th...d by probiotic producers to identify strains that ...obiotics need to interact with cells lining the gu...to surfaces in the gut they are more likely to sti...ys Dr Nathalie Juge from the Institute of Food Res...
(Date:11/24/2009)...College of Medical Toxicology (ACMT) have signed a...he Journal of Medical Toxicology (JMT), the offi... It was previously published by the University of...Toxicology , an international, peer-reviewed journ...tice of medical toxicology. The quarterly journal...
(Date:11/24/2009)...d is a matter of debate. A high-profile study a fe...ent of their carbon from trees and leaves, evidenc...d aquatic ecosystems. , But new research from th...y to be true. Algae provide a much richer diet for...h published this week in the Proceedings of the N...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2Springer and the American College of Medical Toxicology to work together 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3June 18 Conference Features Legal Medical 26 Scientific Presentations 47511 1June 18 Conference Features Legal Medical 26 Scientific Presentations 47511 2June 18 Conference Features Legal Medical 26 Scientific Presentations 47511 3Most common brain cancer may originate in neural stem cells 47510 1Most common brain cancer may originate in neural stem cells 47510 2Most common brain cancer may originate in neural stem cells 47510 3Most common brain cancer may originate in neural stem cells 47510 4When lawn mowers attack 47508 1When lawn mowers attack 47508 2
...new genetic mutation responsible for osteogenesis ... more likely to break, according to a study publis...erience just a few fractures in a lifetime or seve...Americans affected is unknown, but estimates range...rtant early step in the search for a cure, its imm...
...sylvania School of Veterinary Medicine have discov... systems of fish and mammals in the form of a prim... immune system. Their studies link the evolution ...cells produce antibodies to fight infection, to th...ey found that B cells take part in phagocytosis (l...
...n identified by Monash University scientists inves... a gene involved in cancer development. , A team l...epartment of Immunology, has identified two protei...ducing a protein called telomerase that is essenti...se plays a key role in controlling the life span o...
Other Biology News:Researchers discover new gene responsible for brittle bone disease 2Researchers discover new gene responsible for brittle bone disease 3'Killer' B cells demonstrate evolutionary link between fish and mammal immune systems 2'Killer' B cells demonstrate evolutionary link between fish and mammal immune systems 3New target for cancer therapy identified 2
MBS Satellite Thermal Cycler from Thermo Scientific
...mates LC microfractionaction, spotting and prepara...LC eluent can be accurately and continuously spott... Matrix solutions can be added automatically. This... for MALDI-TOF-MS measurements. By using it in con...
CQCS kit for etra KR 4i from Thermo Scientific
...s a microprocessor controlled, high speed filter w...lly smooth operation make the Lambda 10-2 ideal fo...roscopy, ratio imaging, spectrophotometry, visual ... accurate aperture positioning. The Lambda 10-2 co...
Biology Products: